CAGE Bio Announces Collaboration to Advance First-in-Class Treatments for Cutaneous Graft versus Host Disease

SAN CARLOS, Calif. and DALLAS, Aug. 27, 2025 /PRNewswire/ -- CAGE Bio Inc., a leader in advancing innovative therapies for targeted and localized treatment of immunological skin diseases, today announced it has entered into a collaboration with Mayo Clinic to…